Overview

A Follow-up Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome

Status:
Enrolling by invitation
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the long-term safety, tolerability and the long-term efficacy of rotigotine treatment in adolescents with idiopathic Restless Legs Syndrome (RLS).
Phase:
Phase 3
Details
Lead Sponsor:
UCB Biopharma S.P.R.L.
Treatments:
Rotigotine